Terms: = Colorectal cancer AND LYL1, P12980, 4066, ENSG00000104903
4 results:
1. Global and targeted serum metabolic profiling of colorectal cancer progression.
Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
[TBL] [Abstract] [Full Text] [Related]
2. Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol.
Kuijpers AM; Mirck B; Aalbers AG; Nienhuijs SW; de Hingh IH; Wiezer MJ; van Ramshorst B; van Ginkel RJ; Havenga K; Bremers AJ; de Wilt JH; Te Velde EA; Verwaal VJ
Ann Surg Oncol; 2013 Dec; 20(13):4224-30. PubMed ID: 23897008
[TBL] [Abstract] [Full Text] [Related]
3. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
[TBL] [Abstract] [Full Text] [Related]
4. [Undifferentiated small cell carcinoma (oat-cell type) of the colon. Prognostic and therapeutic implications].
Acea Nebril B; Bouso Montero M; Arnal Monreal F; Gómez Freijoso C; Sánchez González F; Freire Rodríguez D
Rev Esp Enferm Dig; 1996 Aug; 88(8):533-8. PubMed ID: 8962757
[TBL] [Abstract] [Full Text] [Related]
